Form 4 for TECH Bio-Techne
Accepted 2022-08-25 00:00:00 ET · period of report 2022-08-23 · accession 0001437749-22-021367 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-25 | 2022-08-23 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $150.78 | +663 | 3,801 | +21% | +$100.0K |
| D | 2022-08-25 | 2022-08-23 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | -663 | 6,848 | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-23 | M | A | 663 | $150.78 | 3,801 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-08-23 | M | D | 663 | $0.00 | 6,848 | D | $150.78 · — to 2025-05-01 | 663 Common Stock | (F1) Fully exercisable. |